2 year old child with ALL, which of the following has the best prognosis?
**Core Concept**
The prognosis of Acute Lymphoblastic Leukemia (ALL) in children largely depends on the presence and characteristics of specific genetic abnormalities, particularly the Philadelphia chromosome (BCR-ABL fusion) and other high-risk cytogenetic features. The outcome of ALL treatment is also influenced by the child's age at diagnosis, white blood cell count at presentation, and response to initial therapy.
**Why the Correct Answer is Right**
The best prognosis in a 2-year-old child with ALL is associated with the presence of the ETV6-RUNX1 fusion gene. This genetic abnormality is commonly found in infant ALL (less than 1 year of age) and is often associated with a favorable response to chemotherapy. The ETV6-RUNX1 fusion gene is thought to result from a reciprocal translocation between chromosomes 12 and 21 (t(12;21)(p13;q22)). Children with this genetic abnormality tend to have a higher likelihood of achieving complete remission and long-term survival.
**Why Each Wrong Option is Incorrect**
* **Option A:** MLL gene rearrangements are associated with a higher risk of relapse and a poorer prognosis in children with ALL.
* **Option B:** The BCR-ABL fusion gene, resulting from the Philadelphia chromosome (t(9;22)(q34;q11)), is typically associated with a poorer prognosis in ALL, particularly in older children and adults.
* **Option D:** Hyperdiploidy is a favorable cytogenetic feature in ALL, but it is more commonly found in children older than 1 year of age, and its prognosis may not be as favorable as that of the ETV6-RUNX1 fusion gene.
**Clinical Pearl / High-Yield Fact**
In children with ALL, the presence of the ETV6-RUNX1 fusion gene is a strong predictor of a favorable outcome, and these patients may be considered for less intensive chemotherapy regimens.
**Correct Answer:** C.